Pralidoxime
Ended Awarded
- Contract number
- HHSD2002017F94479
- Awardee
-
Baxter Healthcare Corporation UEI RSKLEFCZ6127
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $12,209,375
Award facts
- Opportunity
-
- 2017Q66775 Solicitation number
- Contract value 100% obligated
- $12,209,375.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of the pharmaceutical product PRALIDOXIME to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The contract was awarded to the prime contractor Baxter Healthcare Corporation, doing business as Baxter Health Systems, on June 29, 2017, with a completion date of November 30, 2017. The contract has a firm fixed price of $12,209,375.20 and was awarded under the General Services Administration (GSA) Pharmaceutical and Drugs Schedule (FSS-61-IB). Baxter Healthcare Corporation is a for-profit organization and manufacturer of medical devices, pharmaceuticals, and biotechnology products. This award was not set aside for a specific business category.
Quick answers
Who was awarded contract HHSD2002017F94479?
HHSD2002017F94479 was awarded to Baxter Healthcare Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 29, 2017.
How much is contract HHSD2002017F94479 worth?
The government has obligated $12,209,375 on HHSD2002017F94479.
Is contract HHSD2002017F94479 an order under another contract?
Yes. HHSD2002017F94479 is a delivery order under V797P5032B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HHSD2002017F94479 competed?
The extent of competition for HHSD2002017F94479 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award